Detecting nonpalpable recurrent breast cancer: The role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions

Radiology

Volumn 248, Issue 2, 2008, Pages 398-405

  Lee, Janie M ^a   Georgian Smith, Dianne ^b   Gazelle, G Scott ^a   Halpern, Elkan F ^a   Rafferty, Elizabeth A ^a   Moore, Richard H ^a   Yeh, Eren D ^b   D'Alessandro, Helen A ^a   Hitt, Rachel A ^a   Kopans, Daniel B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; COHORT ANALYSIS; FEMALE; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; AGED; BREAST RECONSTRUCTION; BREAST TUMOR; DECISION SUPPORT SYSTEM; MASTECTOMY; MIDDLE AGED; MORTALITY; PLASTIC SURGERY; RADIOGRAPHY; RECTUS ABDOMINIS MUSCLE; TRANSPLANTATION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MAMMAPLASTY; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTUS ABDOMINIS; RETROSPECTIVE STUDIES; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 49049104433     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2482071635     Document Type: Article

References (27)

1. Helvie MA, Bailey JE, Roubidoux MA, et al. Mammographic screening of TRAM flap breast reconstructions for detecting nonpalpable recurrent cancer. Radiology 2002;224:211-216.
2. Edeiken BS, Fornage BD, Bedi DG, Sneige N, Parulekar SG, Pleasure J. Recurrence in autogenous myocutaneous flap reconstruction after mastectomy for primary breast cancer: US diagnosis. Radiology 2003;227:542-548.
3. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) Atlas. Reston, Va: American College of Radiology, 2003.
4. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999;17:1080-1082.
5. Langstein HN, Cheng MH, Singletary SE, et al. Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg 2003;111:712-720.
6. Carlson GW, Styblo TM, Lyles RH, et al. The use of skin sparing mastectomy in the treatment of breast cancer: the Emory experience. Surg Oncol 2003;12:265-269.
7. Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 1998;5:620-626.
8. Gerber B, Krause A, Reiner T, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 2003;238:120-127.
9. Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 1999;6:676-681.
10. Spiegel AJ, Butler CE. Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction. Plast Reconstr Surg 2003;111:706-711.
11. Medina-Franco H, Vasconez LO, Fix RJ, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 2002;235:814-819.
12. Kroll SS, Khoo A, Singletary SE, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg 1999;104:421-425.
13. Fersis N, Hoenig A, Relakis K, Pinis S, Wallwiener D. Skin-sparing mastectomy and immediate breast reconstruction: incidence of recurrence in patients with invasive breast cancer. Breast 2004;13:488-493.
14. Slavin SA, Schnitt SJ, Duda RB, et al. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg 1998;102:49-62.
15. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-175.
16. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-360.
17. Nystrom L, Ingvar A, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-919.
18. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"): I. Validation of the method. Am J Med 1982;73:883-888.
19. Arias E. United States life tables, 2002. In: National vital statistics reports. Hyattsville, Md: National Center for Health Statistics, 2004; 1-39.
20. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997;127:955-965.
21. Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology 2006;241:55- 66.
22. American Cancer Society. American Cancer Society guidelines for the early detection of cancer. Atlanta, Ga: American Cancer Society, 2007.
23. National Cancer Institute. National Cancer Institute fact sheet. Screening mammograms: questions and answers. Bethesda, Md: National Cancer Institute, 2007.
24. American College of Radiology. ACR practice guideline for the performance of screening mammography. Reston, Va: American College of Radiology, 2007.
25. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997;22:79-86.
26. Shapiro S, Venet W, Strax P, Venet L. Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of Greater New York Study. In: Day NE, Miller AB, eds. Screening for breast cancer. Toronto, Ont: Hans Huber, 1988; 3-15.
27. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mamography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87-92.